Express Scripts Sees Rx Drug Cost Increases Under 10% As Manageable
Active management of pharmacy benefits that results in prescription cost increases of less than 10% would be acceptable to Express Scripts.
You may also be interested in...
Express Scripts expects the complexity of its formulary services will help the PBM to secure a leading role in the use of hand-held physician prescribing devices.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials